Pediatric Elective Intubation With and Without Muscle Relaxation Utilizing the Shikani Optical Stylet

NCT ID: NCT00912990

Last Updated: 2020-08-18

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Clinical Phase

NA

Total Enrollment

34 participants

Study Classification

INTERVENTIONAL

Study Start Date

2007-01-31

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The investigators' primary specific aims are to demonstrate that:

1. Pediatric patients with normal airways, undergoing elective surgical procedures, can be successfully intubated when deeply sedated, without the use of muscle relaxants using the Shikani Optical Stylet.
2. Shikani intubation of pediatric patients is equally effective in children that are deeply sedated or paralyzed as evidenced by a non-significant difference in:

* Time to intubation (defined as no more than a 30 second time difference between the two groups);
* Incidence of adverse events.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Intubation,Endotracheal

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

QUADRUPLE

Participants Caregivers Investigators Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Normal saline

Normal saline volume calculated to be equal to the volume of cisatracurium 0.2mg/kg

Group Type PLACEBO_COMPARATOR

Normal saline

Intervention Type DRUG

One Intravenous dose

Cisatracurium

Subjects in this arm will be given Cisatracurium 0.2mg/kg IV dose one time prior to intubation.

Group Type ACTIVE_COMPARATOR

Cisatracurium

Intervention Type DRUG

One intravenous dose: 0.2mg/kg/dose

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cisatracurium

One intravenous dose: 0.2mg/kg/dose

Intervention Type DRUG

Normal saline

One Intravenous dose

Intervention Type DRUG

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Nimbex

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 6 months of age to 17 years of age (not yet 18)
* Male or female
* English or Spanish speaking
* Normal airway (Mallampati Classification )
* American Society of Anesthesiology Physical Status Classification I or II
* Elective surgical procedure expected to last at least 45 minutes in length
* Written informed consent/assent for participation given by the parent legal guardian and subject (if applicable)

Exclusion Criteria

* \< 6 months of age, \> 17 years of age
* Difficult airway (Mallampati Classification)
* History of previous difficult intubation, suspected abnormal airway: \*micrognathia

* facial trauma
* airway tumor
* epiglottitis
* retropharyngeal abscess
* foreign body, etc.
* Scheduled for non-elective, emergent OR procedure
* Parent, legal guardian, or subject is unavailable or unwilling to consent for study participation
Minimum Eligible Age

6 Months

Maximum Eligible Age

17 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rady Children's Hospital, San Diego

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Sandeep Khanna

Attending Physician Division of Pediatric Critical Care

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rady Children's Hospital

San Diego, California, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

06104C

Identifier Type: OTHER

Identifier Source: secondary_id

11672

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Extended-release Sodium Oxybate in Children
NCT06809803 RECRUITING PHASE2
Efficacy of Amicar for Children Having Craniofacial Surgery
NCT02229968 ACTIVE_NOT_RECRUITING PHASE2
Lorazepam Sedation for Critically Ill Children
NCT00109395 COMPLETED PHASE2/PHASE3